BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Subbarao K. Live Attenuated Cold-Adapted Influenza Vaccines. Cold Spring Harb Perspect Med 2021;11:a038653. [PMID: 32253347 DOI: 10.1101/cshperspect.a038653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Faizuloev EB, Korchevaya ER, Gracheva AV, Samoilikov RV, Smirnova DI, Sokolova OS, Glukhov GS, Moiseenko AV, Leneva IA, Nagieva FG, Svitich OA, Zverev VV. Biological characterization of cold-adapted SARS-CoV-2 variants. Zhurnal mikrobiologii, èpidemiologii i immunobiologii 2022;99:397-409. [DOI: 10.36233/0372-9311-280] [Reference Citation Analysis]
2 Emborg H, Vestergaard LS, Botnen AB, Nielsen J, Krause TG, Trebbien R. A late sharp increase in influenza detections and low interim vaccine effectiveness against the circulating A(H3N2) strain, Denmark, 2021/22 influenza season up to 25 March 2022. Eurosurveillance 2022;27. [DOI: 10.2807/1560-7917.es.2022.27.15.2200278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Landgraf G, Desheva YA, Rudenko LG. Assessment of trivalent live influenza vaccines in MDCK cell line. MethodsX 2021;8:101442. [PMID: 34430331 DOI: 10.1016/j.mex.2021.101442] [Reference Citation Analysis]
4 Cardenas-Garcia S, Cáceres CJ, Jain A, Geiger G, Mo JS, Jasinskas A, Nakajima R, Rajao DS, Davies DH, Perez DR. FluB-RAM and FluB-RANS: Genome Rearrangement as Safe and Efficacious Live Attenuated Influenza B Virus Vaccines. Vaccines (Basel) 2021;9:897. [PMID: 34452022 DOI: 10.3390/vaccines9080897] [Reference Citation Analysis]
5 Sun W, Luo T, Liu W, Li J. Progress in the Development of Universal Influenza Vaccines. Viruses 2020;12:E1033. [PMID: 32957468 DOI: 10.3390/v12091033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]